Novel Molecular Targets and Mechanisms Involved in the Invasion and Metastasis of Pancreatic Cancer

Ziyi Li, Weidong Li, Yu-xing Dong, Xueying Sun
{"title":"Novel Molecular Targets and Mechanisms Involved in the Invasion and Metastasis of Pancreatic Cancer","authors":"Ziyi Li, Weidong Li, Yu-xing Dong, Xueying Sun","doi":"10.2174/2212697X06666190328180331","DOIUrl":null,"url":null,"abstract":"Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancerrelated deaths and its morbidity and mortality are increasing. PDAC patients have a very poor prognosis because of aggressive features of PDAC cells, shortage of reliable diagnostic biomarkers and deficiency of effective therapeutics.The article aims to discuss the recent progress in the discovery of novel molecular targets and their related mechanisms in the invasion and metastasis of PDAC cells.Literatures based on Pubmed database were searched and those related to the molecular targets involved in the invasion and metastasis of PDAC were reviewed.The most promising discovery of molecular targets and phenomena include epithelialmesenchymal transition (EMT), cancer stem cells (CSCs), metastasis-related genes, hypoxiainducible factors (HIFs), non-coding RNAs (ncRNAs) and L1 cell adhesion molecule (L1CAM), which contribute to the vital biological behaviors of PDAC cells and tumor microenvironments.This review summarizes recent advances in novel molecular targets that regulate the invasion and metastasis of PDAC cells, and how they are targeted for developing diagnostic and therapeutic tools for combating PDAC. Further understanding the regulatory mechanisms of these molecular targets may help to discover biomarkers used for early diagnosis, predicting the prognosis and monitoring treatment response, and also to develop novel effective therapeutics.","PeriodicalId":91228,"journal":{"name":"Clinical cancer drugs","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/2212697X06666190328180331","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical cancer drugs","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2212697X06666190328180331","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancerrelated deaths and its morbidity and mortality are increasing. PDAC patients have a very poor prognosis because of aggressive features of PDAC cells, shortage of reliable diagnostic biomarkers and deficiency of effective therapeutics.The article aims to discuss the recent progress in the discovery of novel molecular targets and their related mechanisms in the invasion and metastasis of PDAC cells.Literatures based on Pubmed database were searched and those related to the molecular targets involved in the invasion and metastasis of PDAC were reviewed.The most promising discovery of molecular targets and phenomena include epithelialmesenchymal transition (EMT), cancer stem cells (CSCs), metastasis-related genes, hypoxiainducible factors (HIFs), non-coding RNAs (ncRNAs) and L1 cell adhesion molecule (L1CAM), which contribute to the vital biological behaviors of PDAC cells and tumor microenvironments.This review summarizes recent advances in novel molecular targets that regulate the invasion and metastasis of PDAC cells, and how they are targeted for developing diagnostic and therapeutic tools for combating PDAC. Further understanding the regulatory mechanisms of these molecular targets may help to discover biomarkers used for early diagnosis, predicting the prognosis and monitoring treatment response, and also to develop novel effective therapeutics.
胰腺癌侵袭和转移的新分子靶点和机制
胰腺导管腺癌(PDAC)是癌症相关死亡的主要原因,其发病率和死亡率正在上升。由于PDAC细胞具有侵袭性,缺乏可靠的诊断生物标志物和缺乏有效的治疗方法,PDAC患者预后非常差。本文就PDAC细胞侵袭转移过程中新靶点的发现及其相关机制进行综述。检索Pubmed数据库的相关文献,对与PDAC侵袭转移相关的分子靶点进行综述。最有希望发现的分子靶点和现象包括上皮间充质转化(epithelial - mesenchymal transition, EMT)、癌症干细胞(cancer stem cells, CSCs)、转移相关基因、缺氧诱导因子(hypoxiainducible factors, hfs)、非编码rna (non-coding RNAs, ncRNAs)和L1细胞粘附分子(L1 cell adhesion molecule, L1CAM),它们参与了PDAC细胞和肿瘤微环境的重要生物学行为。本文综述了调控PDAC细胞侵袭和转移的新分子靶点的最新进展,以及它们如何被用于开发对抗PDAC的诊断和治疗工具。进一步了解这些分子靶点的调控机制可能有助于发现用于早期诊断、预测预后和监测治疗反应的生物标志物,也有助于开发新的有效治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信